Boothbay Fund Management’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,484
Closed -$53.8K 1846
2025
Q2
$53.8K Hold
4,484
﹤0.01% 1349
2025
Q1
$128K Buy
4,484
+1,776
+66% +$82.7K ﹤0.01% 1213
2024
Q4
$186K Buy
+2,708
New +$91.9K ﹤0.01% 1210

Other funds holding AEMD

Boothbay Fund Management's AEMD Position: Q3 2025 in Review

Boothbay Fund Management sold out of Aethlon Medical (AEMD) in Q3 2025, closing a stake of 4,484 shares — an estimated $53.8K sold.

Boothbay Fund Management first reported a position in AEMD in Q4 2024 and held it in 3 quarters. The position peaked at $186K in Q4 2024. 17 funds tracked by Wall St. Rank hold AEMD as of Q3 2025.

  • Boothbay Fund Management reported no remaining Aethlon Medical position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 4,484 Aethlon Medical shares in Q3 2025, an estimated $53.8K.
  • Boothbay Fund Management first reported a position in Aethlon Medical in Q4 2024 and held it in 3 quarters.
  • Boothbay Fund Management's Aethlon Medical position peaked at $186K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.